Linear decrease in genetic diversity when considering πSNP as a function of the distance to the southernmost sample site. by Quentin Rougemont (3249753)

Simulation of the average densities/concentrations of the variables for model (2)–(21) with/without ENZ (ADT) at <i>γ</i>_<i>E</i> = 10⁻⁷ g/cm³⋅d.... by Nourridine Siewe (5081834)

Linear regressions of pPOM and sPOM stable carbon and nitrogen isotope values versus collection date. by Nathan D. McTigue (10706460)

Constant temperature effects on germination percent data were analyzed using a segmented regression (a) and germination rate data were analyzed using linear regression (b) for 6 po... by Michael C. Beall (18764654)

Percentage of exhale flux penetrating through the mask fabric for different values of <i>c</i>_<i>k</i>; a–c and d–f decreasing porosity for outward and inward protection... by Akshay Anand (118579)

ANOVA a test of the linear regression model. by Dania AL-Najjar (11840857)

Brief Report: Increased technology use associated with lower A1C in a large pediatric clinical population by G. Todd Alonso (9568724)

“…</p> <p><strong>Results</strong><br> CGM use increased from 32.9% to 75.3%; HCL increased from 0.3% to 27.9%. Overall A1C decreased from 8.9% to 8.6% (p<0.0001). </p> <p><strong>Conclusions</strong></p> <p>Adoption of CGM and HCL was associated with decreased A1C, suggesting promotion of these technologies may yield glycemic benefits.…”

Longer polyQ sequences decrease the transcriptional activity of AR. by Carlos M. Roggero (11909585)

Subjects:

Baseline patient characteristics. by Oscar F. C. van den Bosch (22184246)

“…Changes during drug infusion were compared in a linear mixed model to assess the effects of s-ketamine and midazolam compared to saline. …”

Results from linear regression analysis for δ¹³C or δ¹⁵N and collection date. by Nathan D. McTigue (10706460)

Linear regressions of the distance between buoys (km) and the Pearson correlation coefficient for each pairwise buoy combination for 2021 (blue) and 2022 (gray). by Claire Stevens (11127729)

Biases in larger populations. by Sander W. Keemink (21253563)

“…(<b>B</b>) Minimum and maximum bias in a long 1D array with rectified cosine tuning. Bias expressed in terms of the distance between neurons in a linear population of equally spaced neurons. …”

Participant demographics. * P-values were determined using Fisher-Freeman-Halton test when contingency tables are larger than 2 × 2. by Elie Mulhem (22537863)

Mean and standard deviation of maximal walking distance (MWD) and WELSH score and coefficient of correlation (r), slope and intercept of the regression linear analysis between MWD... by Wendsèndaté Yves Sempore (11944701)

The carotid canal area is larger on the unaffected side than on the affected side in patients with unilateral moyamoya disease, but the difference decreases according to the contra... by Yuki Oichi (11840776)

Image_1_The Contribution of Decreased Muscle Size to Muscle Weakness in Children With Spastic Cerebral Palsy.TIF by Britta Hanssen (4898155)

“…To define the contribution of decreased muscle size to muscle weakness, two cohorts were recruited in this cross-sectional investigation: 53 children with SCP [median age, 8.2 (IQR, 4.1) years, 19/34 uni/bilateral] and 31 children with a typical development (TD) [median age, 9.7 (IQR, 2.9) years]. …”

Table_2_The Contribution of Decreased Muscle Size to Muscle Weakness in Children With Spastic Cerebral Palsy.docx by Britta Hanssen (4898155)

“…To define the contribution of decreased muscle size to muscle weakness, two cohorts were recruited in this cross-sectional investigation: 53 children with SCP [median age, 8.2 (IQR, 4.1) years, 19/34 uni/bilateral] and 31 children with a typical development (TD) [median age, 9.7 (IQR, 2.9) years]. …”

Table_3_The Contribution of Decreased Muscle Size to Muscle Weakness in Children With Spastic Cerebral Palsy.docx by Britta Hanssen (4898155)

“…To define the contribution of decreased muscle size to muscle weakness, two cohorts were recruited in this cross-sectional investigation: 53 children with SCP [median age, 8.2 (IQR, 4.1) years, 19/34 uni/bilateral] and 31 children with a typical development (TD) [median age, 9.7 (IQR, 2.9) years]. …”

Table_1_The Contribution of Decreased Muscle Size to Muscle Weakness in Children With Spastic Cerebral Palsy.docx by Britta Hanssen (4898155)

“…To define the contribution of decreased muscle size to muscle weakness, two cohorts were recruited in this cross-sectional investigation: 53 children with SCP [median age, 8.2 (IQR, 4.1) years, 19/34 uni/bilateral] and 31 children with a typical development (TD) [median age, 9.7 (IQR, 2.9) years]. …”

Association of Medicare eligibility and enrollment with healthcare access by income level¹. by Rahul Aggarwal (4428457)